I. INTRODUCTION
Urinary tract infections (UTIs) are the second most common infections in community practice. Incidence of UTI is higher in women than men, 40% to 50% of whom will suffer at least one clinical episode during their lifetime 1 . The increase risk factor for UTI in women may be due to short urethra, absence of prostatic secretions, pregnancy and easy contamination of urinary tract with faecal flora 2 . Approximately 90% of pregnant women develop ureteral dilation, which will persist until delivery 3 . And it may contribute to increased urinary stasis and ureterovesical reflux. Additionally, the physiological increase in plasma volume during pregnancy decreases urine concentration and up to 70% of pregnant women develop glycosuria, which is considered to encourage bacterial growth in the urine 3, 4 . Thus UTIs are the most common bacterial infections during pregnancy, with pyelonephritis being the most common severe bacterial infections complicating pregnancy 5 . Recurrent infection cause considerable morbidity,if complicated ,it can cause severe renal disease 6 . Modern medical management of UTI includes chiefly antibiotics.Use of antibiotics for long time in pregnancy may cause bad effects on growing fetus and presently chance of resistance is high. Due to development of resistance to present day antibiotics there is a need to evaluate newantibiotics which are equally effective. Although a lot of classical references of drugs on Mutrakrichhra 7, 8 are available in Ayurvedic texts. It is imperative for us toprove the antimicrobial properties of thementioned drug using scientific parameters. Acharya Sushruta 9 and Acharya Charak 10 , has explained Mutrakrichhra under Mutravahastroto DusthiVikar. Symptoms of U.T.I. like Burning Micturition, Abdominal pain, and increased Frequency are same in Mutrakrichchra Vyadhi. The symptoms of Urinary tract infections during pregnancy are nearer to those of mutrakrichhra. In the Ayurvedic texts, Acharya Kashayap have described the treatment of mutrasanga and mutragraha respectively, among the garbhini Vyadhi"s.This depicts the importance to observe the symptoms carefully and timely treat the disease. In the routine antenatal check-up, the signs and symptoms of Mutrakrichhra are generally present which are similar to those of U.T.I. So the present study has been taken on Garbhini Mutragraha w.s.r to Urinary tract infections during pregnancy using the Mutragrahahar Yog described by Acharya Kashyap in khilasthana 11 and to see the drugs in the light of objective as well as subjective criteria if found to be effective . So 
1) Method of Preparation of Trial Drug
The drugs was prepared in the college pharmacy under the supervision of the subject expert as per the classical methods.
B. Kwatha Kalpana
All the contents of the combination drug were collected , identified dravyaguna deptt. , dried in shade and coarse powder (yavkut) was made by taking all the ingredients inequal quantity , 1 pal quantity of coarse powder mixed with 16 times water and boiled at low flame till 1/8 th i.e. 2 pala is left. This is called kashaya. It was advised to be taken in divided dosage to the patients.
1)
Synonyms -Shrit, Kwath, Kashaya, Niryuh, Decoction. 
4) Exclusion Criteria
 Polycystic kidneys, Hydronephrosis.  Impaired renal functions. 
5) Dose
The registered patients were given the trial drug i.e Mutragrahahar yog Kwatha in dose of 100ml BD.
6) Trial Group
Total 15 patients were selected for the present study who fulfilled inclusion criteria. All the selected patients were studied in single group. All the 15 patients completed the trial. 
7) Investigations
Routine blood, urine and USG examinations were carried out to rule out any other pathology.
8) Assessment of the Patients:-
Assessment of the effects of therapy was done on the basis, of various subjective and objective criteria. Patients were, assessed after one week of the commencement of clinical trial and after completion of trial i.e. after 15 days. In first follow up, the patients were assessed on clinical grounds only. The patients who did not come for follow up were considered drop out. At the end of 15 th days, final detailed examination of the patients was, carried out including all investigations.
9) Assessment Criteria:-
Assessment of clinical features on subjective criteria (sadah mutrata (burning micturition), saruja mutrata (painful micturition), krachhra-mutrata (difficulty in micturition),muhur-muhur mutrata (increased frequency of micturition) urgency, suprapubic pain) and objective criteria (presence of Albumin, Epithelial Cells, Pus Cells, Rbc in urine) was assessed by evaluating already mentioned laboratory findings, which were carried out at the time of commencement of clinical trial. some of these were assessed by grading them and other were assessed by simply evaluating the results obtained from them as follows.
C. Statistical Analysis of Results
The information gathered regarding demographic data was given in percentage. The data related to clinical features and laboratory investigations was collected and then statistically analyzed. 
D. Total Effect of Therapy
Steps for calculating overall percentage of improvement of individual patient; All the BT score of every symptoms of a patient were added. All the AT score of every symptom of that patient were added. Overall percentage of improvement of each patient was calculated by the formula:
(Total BT -Total AT) / Total BT X 100. The obtained results were measured according to the grades given below:  Complete Remission :
100% relief  Marked Improvement : ≥75% relief  Moderate Improvement: 50 % to 75 % relief  Mild Improvement : <50 % relief  Unchanged : <25 % or No relief
III. OBSERVATIONS AND RESULTS
A total of 15 subjects were registered in the present study, and all the patients completed the trial. 40% were observed in age group of 26 -30 yrs and 26% were observed in age group of 21-25yrs. 53% were observed to be affected at fetal gestational age of 24 -28 weeks, 53% patients were primigavida, 80% patients belonged to rural habitat, 80% were house wives, 20% were in service. 46% patients were educated up to Primary level and 33% patients were illiterate or uneducated. 73% patients were of lower middle class following 27% patients were of lower socioeconomic class. 67% patients were vegetarian & 33% patients were on mixed diet. 60% patients were of Vata-pittaja prakriti, 26% patients were of kapha-Pittaja prakriti and 14% patients were of kaphaja-pittaja prakriti, 46% of patients had decreased appetite, 60% had regular bowel habit and 30% patients had constipation, 40% were ISSN: 2393 -9117 www.internationaljournalssrg.org Page 14
following medium hygiene, 40% of patients had poor hygiene, 73% patients were having samyaka sleep, 20% patients were of decreased (alpa) sleep & 7% were of excessive(ati) sleep, 53% had frequency of micturition 11-20 times/day followed by 33% patients having frequency of micturition of 6-10 times/day and 20% patients were having frequency of micturition more than 21 times/day. Among 15 registered patients 100% had increased frequency of micturition , 93% patients had burning micturition,73% patients had suprapubic pain, 67% patients had urgency of micturition ,47% patients had difficult micturition and 40% patients had painful micturition. Urine analysis shows that all patients i.e. 100% having yellow coloured and acidic urine , pus cells and epithelial cells. Albumin was observed in patients i.e. 40% , R.B.C. was observed in 20%patients.
A. Effects of the Therapy:
A total of 15 patients were registered for present clinical study. All patients completed the trial. and snigdha guna and these gunas are vatashamaka and malavardhaka.  All constituents of drug have sheet virya which makes drug as prasadaka and clears strotas avrodha.  Madhur vipaka of most of the constituents leads to srishta-vittamutra maruta thus causing diuresis.  Drug also has pitta shamaka as well as vata shamaka properties along with mutra virechaniya and vedna shamaka action.  Kshiramorat, Darbhmoola are rasayana thus enhance the immune response of body.  Darbhmoola has antibacterial action against Staphylococcus aureus.  Madhuk also has antibacterial action  Saponins present in Shatavari are responsible for its diuretic action.  Triterpinoids in darbha are responsible for its anticancer activity. Mutragrahahar yog kwath is a mutravirechaneeya drug. The mutra virechaneeya drugs perform their action by decreasing the agneyatatva and increasing the jaliya tatva in the urine. They act by their pittashamana, vatanulomana and srotodahahara karma.
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IV. SUMMARY  U.T.I is a common problem in pregnancy.  It is concluded from the discussion of present study that mutragraha which has been tried to study taking into account the signs and symotomatology of mutrakrichhra may be explained as Urinary Tract Infection (UTI) in modern days.  The drug Mutragrahahar yog acts by its antibacterial, immunomodulatory, adaptogenic, deepan-pachan, vata-pitta shamak, vatanulomak and diuretic action.  Mutragrahahar yog showed effective result in reducing the subjective and objective critreia of U.T.I in pregnant patients.  It was noticed that all the patients tolerated the treatment quiet well and no adverse reaction to the drugs were observed during the course of treatment. Thus, it can be concluded from the present study that trial drugs are safe and effective in the management of Garbhini Mutragraha.
V. CONCLUSION
• This study is carried out in a small sample. For better Exploration of the study in Large sample is necessary.
• Urinary tract infections are a common cause of serious maternal and perinatal morbidity. All pregnant women should be screened for bacteriuria.
